{"lastClose": 51.099998474121094, "len": 1636, "date": "2022-11-02", "alpha_5": 0.4568160616507635, "beta_5": 1.8074431005378138, "drawup_5": 17.726695618361344, "sharpe_5": 0.5232977818552713, "natr_5": 13.560168326191274, "sup_5": -0.8621656522259095, "res_5": 1.0525766825092318, "bullPattern_5": [], "bearPattern_5": ["ENGULFING", "SHORTLINE"], "rsi_5": 46.38832859154369, "adx_5": 5.997820033807778, "drawdown_5": -0.7822717391998621, "alpha_1": -0.5894045479163006, "beta_1": 2.1624990465878784, "drawup_1": 0.8628213515603638, "sharpe_1": -0.7205788437991185, "natr_1": 13.560168326191274, "sup_1": -0.1742334287231633, "res_1": 0.1609263309523948, "bullPattern_1": ["DOJI", "GRAVESTONEDOJI", "LONGLEGGEDDOJI"], "bearPattern_1": [], "rsi_1": 40.26571367903111, "adx_1": 26.69350320917224, "drawdown_1": -0.7218126517152739, "alpha_3mo": -0.6022005408523854, "beta_3mo": 1.7295418444563373, "drawup_3mo": 0.2641474991899482, "sharpe_3mo": -0.6159424803984812, "natr_3mo": 13.560168326191274, "sup_3mo": -0.1304631231736171, "res_3mo": 0.05238097086611353, "bullPattern_3mo": ["INVERTEDHAMMER"], "bearPattern_3mo": [], "rsi_3mo": 41.47896357023027, "adx_3mo": 15.521603318595535, "drawdown_3mo": -0.29031792257978106, "Sector": "Health Care", "Market Cap": 3884202162, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "IPO Year": 2016.0, "Country": "United States", "Name": "Intellia Therapeutics Inc.", "alpha%_5": 0.9958771756891278, "beta%_5": 0.9932809989084, "drawup%_5": 0.9999999999999977, "sharpe%_5": 0.7568872682053567, "natr%_5": 0.9999999570976604, "drawdown%_5": 0.17419915619802112, "alpha%_1": 0.115981167248281, "beta%_1": 0.9879515676994101, "drawup%_1": 0.9155553552319409, "sharpe%_1": 0.2954396969265307, "natr%_1": 0.9994189779907238, "drawdown%_1": 0.08117739667911655, "alpha%_3mo": 0.2728822270439796, "beta%_3mo": 0.9462775200142994, "drawup%_3mo": 0.773120982047707, "sharpe%_3mo": 0.43830856574081445, "natr%_3mo": 0.9991931785549129, "drawdown%_3mo": 0.31389046396671305}